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THE USE OF SULFAGUANIDINE FOR PROPHYLAXIS
IN SONNE BACILLARY DYSENTERY, AND IN
THE CONTROL OF THE CARRIER STATE*
HERMAN YANNET, JOYCE V. DEUTSCH, AND ROSE LIEBERMAN
In an earlier paper the therapeutic effectiveness of sulfathiazole
used during the acute stages of Sonne bacillary dysentery was dem-
onstrated.5 However, it was shown also that sulfonamide therapy
did not curtail the period during which the Sonne organism could
be recovered by rectal cultures. Actually, there appeared to be sta-
tistical evidence that this period was prolonged when compared with
untreated controls. Another outbreak of Sonne bacillary dysentery
occurring two years later afforded us the opportunity to test the
value of sulfaguanidine, administered for varying periods during
convalescence, for reducing the length of the carrier state. At the
same time, the prophylactic value of the sulfonamide drugs in pre-
venting the epidemic spread of bacillary dysentery, as recently
suggested,2' 4 was also investigated.
Methods and procedures
Material for culture was obtained by means of rectal swabs. The bac-
teriological and cultural technics were those previously described.5 Every
individual with acute dysentery was immediately transferred to the institution's
hospital for treatment. The four cottages in which the disease appeared were
quarantined. With few exceptions, the patients were returned to their
respective cottages after about 7 days. At this time, the administration of
sulfaguanidine was started and continued for the following 7 or 14 days.
The dose of sulfaguanidine was approximately 0.08 gm. per kilogram per day,
divided inito two doses. The usual dose varied between 2 and 3 grams per
day. Every patient was cultured on admission to the hospital, and was fol-
lowed with weekly cultures until 2 consecutive cultures failed to show the
dysentery bacillus. Although cultures obtained while sulfaguanidine was
being administered were negative, not infrequently cultures became positive
after the drug was stopped, consequently no patient was considered bacterio-
logically negative unless at least 2 negative cultures were obtained during the
period when no drug was being given.
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The procedures followed in the experiments on the prophylactic uge of
the sulfonamide drugs will be described together with the results.
Description of the outbreak and the clinical features
The cases of bacillary dysentery were confined to 4 cottages, housing
from 40 to 70 inmates each. The first case appeared on August 23 and the
last case on November 1 1, 1943. A total of 29 cases occurred, representing
from 10 to 20 per cent of the inmates of the respective cottages involved.
The last case became bacteriologically negative on January 5, 1944. It is
interesting to note that the interval between the first and last case, and the
time required for all those who carried the dysentery bacillus to become
negative were almost identical with similar data obtained in the earlier out-
break in 1941.
The Sonne organism was isolated from every case of acute dysentery.
It resembled the 1941 strain biochemically in every respect, except that it
fermented rhamnose in 1 day as compared to the much longer period required
by the other strain,-as long as 11 days in some cases.
Clinically, the disease was of moderate severity. All patients showed
fever ranging from 100° to 1040 F., and averaging about 1020 F. Vomit-
ing occurred in practically every case. Only 2 patients showed significant
amounts of blood in their diarrheal stools. Recovery was complete in every
case, and there were no relapses. An interesting observation relates to the
possibility of the development of a relative immunity. Approximately 30
children who had contracted bacillary dysentery in the 1941 outbreak were
exposed to the disease in 1943. On the basis of our past experience, since
most of these were under 15 years of age, one might have expected at least
20 per cent, or 6 children, to have become involved in this outbreak. Actu-
ally only one young boy from this group became ill.
Six patients received sulfathiazole by mouth in the usual manner for from
2 to 4 days in doses of approximately 0.12 gm. per kilogram per day. Fifteen
patients, because of intractable vomiting, received a single dose of sodium
sulfathiazole by hypodermoclysis. The amount given was approximately
0.06 gm. per kilogram of body weight. It was dissolved in from 750 to
1000 cc. of physiological saline containing 5 per cent added glucose. It was
not the purpose of this study to evaluate the effect of sulfathiazole adminis-
tered during the acute phase of the disease. This was discussed in an earlier
paper.5 However, the clinical response in those given the single dose of sulfa-
thiazole subcutaneously, especially in the more seriously ill patients, was in
every respect as satisfactory in shortening the period of fever and diarrhea as
was noted in the 1941 group that received the drug by mouth in the conven-
tional manner and dosage for an average of 4 days.
There were no untoward effects that could be attributed to the prolonged
use of sulfaguanidine, or to the sulfathiazole.
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Results
1. Efect of sulfaguanidine on the carrier state.
As was mentioned earlier, although the administration of sulfa-
thiazole during the acute illness was of definite dinical benefit, the
carrier state interval was not reduced as compared to untreated con-
trols. There was, on the other hand, suggestive statistical evidence
that it was actually prolonged. It was hoped that the administra-
tion of a poorly absorbed drug, such as sulfaguanidine, might correct
this-defect. The 29 cases were divided into two groups; one con-
sisting of 18 patients receiving sulfaguanidine for 7 days; the
remaining 1 cases, receiving the drug for 14 days. The results of
this study are summarized in Table 1. It will be noted that there
was no significant change in the length of the period during which
cultures were positive in the group receiving sulfaguanidine for 7
TABLE 1
EFFECT OF SULFAGUANIDINE ON THE CARRIER STATE
Days before first
Group Number negative culture
Sulfaguanidine given for 7 days 18 40.3 4 4.9**
(7-90)***
Sulfaguanidine given for 14 days 11 23.6 =1: 5.5
(7-67)
No specific treatment* 17 19.7 ± 3.7
(4-48)
Sulfathiazole during acute stages only* 27 33.9 ± 4.4
(7-84)
* Data obtained from previous study.6
** Standard error.
*** Range.
days when compared with the earlier sulfathiazole-treated group.
In the group receiving sulfaguanidine for 14 days, however, the-
carrier state period was approximately halved. The number of days
before the first of the consistently negative cultures was obtained
is, however, not significantly different from that in- the group that
received no specific drug therapy. It is apparent that the adminis-
tration of sulfaguanidine in the dosage used in this study, even for
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relatively prolonged periods does not materially affect the carrier
state following acute bacillary dysentery. Opper and Hale,3 on the
other hand, found that the administration of 4 gm. of sulfaguanidine
a day for 7 days to a series of adult inmates of a mental hospital in
whom bacillary dysentery had occurred, or who were found to be
healthy carriers of the organism (Flexner) did appreciably diminish
the length of the carrier period. Since the average age of our
patients was 13 years, the dosage of sulfaguanidine employed in our
study was probably not greatly dissimilar to that used by Opper
and Hale, when considered on the basis of weight. The explanation
for the difference in results may be dependent on the inclusion of
healthy carriers in the latter series. It has been our experience, in
this as in the iearlier outbreak, that, with few exceptions, the healthy
carrier discovered during epidemics usually becomes bacteriologically
negative whether treated with sulfaguanidine or untreated in a much
shorter period of time than do those individuals who contract the
disease.5
II. Results of the prophylactic use of sulfaguanidine in epi-
demic Sonne dysentery.
In two of the cottages it was possible to carry out controlled
experiments on the possible prevention of bacillary dysentery by
means of sulfaguanidine.
A.-The first cottage housed 71 middle-grade girls of an aver-
ageage of 17 years. On September 30, 6 girls became acutelyill with
vomiting, diarrhea, and fever. Rectal swabs of every one of these
were positive for the Sonne organism. The following day 22 girls
were started on sulfaguanidine prophylaxis, receiving 2 gm. a day
for 14 days. As a control group, 31 girls of approximately the same
average age were chosen. All the girls took their meals in a com-
mon dining-room, and used common playrooms and bathrooms.
The entire cottage was, of course, quarantined. Within the first
week, 6 girls from the control group developed typical acute bacil-
lary dysentery, bacteriologically proved. No case of dysentery
occurred in the group receiving the sulfaguanidine.
B.-The second cottage, with two dormitories, housed 52 high-
grade boys with an average age of about 10 years. On October 25,
the Sonne organism was isolated from 4 boys who had developed
vomitinganddiarrhea, The nextday, 26 boys in one dormitory were
divided into 2 groups of approximately equal age. The first group
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of 14 boys received 2 gm. of sulfaguanidine a day for 10 days. The
remaining 12 boys were used as controls. A common playroom,
dining-room, and bathroom were used. Between October 28 and
November 1, 3 cases of typical bacillary dysentery developed in the
untreated control group. None of the boys receiving sulfaguanidine
developed the disease.
C.-Another experience along the same line should be described
although, in this case, unfortunately, there were no adequate con-
trols. On October 25, 26 young boys averaging 9 years of age, and
using one dormitory in the cottage described above, became ill with
vomiting and in most cases with diarrhea. None of the children
had fever. Rectal cultures were obtained on all, and from 4 cases
the Sonne organism was isolated. The children were entirely well
within 12 hours. It was felt that some article of food had become
contaminated with the Sonne dysentery bacillus and that the symp-
toms were essentially those of food poisoning due to the Sonne
bacillus exotoxin, and not an actual bacterial infection at this time.
Although the suspected food (potato salad with dressing) was not
available for culture, in a similar experience, previously reported,5
it was possible to isolate the organism from the offending food. It
may be reasonably assumed that practically all of these children
had ingested varying numbers of dysentery bacilli, since on October
29, 2 boys from this group developed typical symptoms of bacillary
dysentery, and on October 30, 2 additional boys became similarly
affected. At this time the remaining 22 boys were given a single
dose of sulfathiazole varying from 1.5 to 2 gm., depending on
weight. No further cases occurred in this group until 12 days later,
when one boy developed acute dysentery. This probably repre-
sented a later contact infection. Since at the time the sulfathiazole
wasgiven, 10 per cent ofthe boys had shown evidence ofthe disease,
it is possible that all the susceptible children were already involved,
and the relatively sudden termination of the outbreak in this group
was not related to the administration of sulfathiazole. The results,
however, were definitely suggestive, and this method of prophylaxis
is worthy of further trial under similar epidemiological conditions.
Discussion
Although acute bacillary dysentery, as described above, is essen-
tially a self-limited disease, presenting as a rule no serious medical
problem, the marked increase in nursing care which becomes neces-
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sary makes an outbreak of this type an exceedingly troublesome
institutional problem. The disease is highly infectious, and tends
to spread from cottage to cottage in spite of presumably adequate
effortsto preventthis spread. While the original cases are probably
dependent on the introduction into the community of a healthy car-
rier, the subsequent spread is more likely related to the relatively
long carrier state that exists in the recovered cases. The part played
by insect vectors in an institution with modern sanitary equipment
is probably not significant. During the course of this outbreak,
various attempts to isolate the organism from flies, collected in the
involved cottages, were unsuccessful.
It is reasonable to expect that any measure that might signifi-
cantly reduce the length of time during which organisms are elimi-
nated in the stools would shorten the course of the outbreak.
Unfortunately, there was no evidence that sulfaguanidine, as used
in this study, was effective in this respect. The average length of
time that rectal cultures remained positive in the sulfaguanidine-
treated groups was not significantly decreased when compared with
the earlier untreated controls in the 1941 outbreak. Moreover, the
epidemic extended for a period of approximately 80 days in both
outbreaks, and the time elapsing before all previously positive cul-
tures became negative was about the same, roughly 4 months, in both
cases.
It is not unlikely that the dose of sulfaguanidine employed for
this purpose may have been too small. This is suggested by the
observation that of 21 rectal cultures taken while the drug was
being administered 13 were positive for the Sonne organism. The
dose employed was approximately one-quarter of that recommended
for treatment of the acute disease. A more satisfactory result was
obtained by Hoagland, Harris, and Raile' in shortening the carrier
state by using 20 gm. a day for 6 days in adult carriers. Because
of the importance of reducing the length of the carrier state, and
the relative innocuousness of the poorly absorbed sulfonamide drugs,
the use of doses larger than those employed in our study is definitely
indicated for future investigation.
The value of sulfaguanidine, when used as a prophylactic meas-
ure in preventing the spread of bacillary dysentery in groups living
under family-like conditions of intimacy, appears definite. Sug-
gestively similar results have been reported by others. Lucchesi
and Gildersleeve2 treated 45 children exposed to Flexner dysentery
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with sulfaguanidine with the usual therapeutic doses of 0.3 gm. per
kilogram per day for the first day and one-half this dose for the
following two days. None of these children developed the illness;
whereas, in an adjoining wing housing 48 children acting as controls,
4 cases developed. Both groups consisted of patients with scarlet
fever, either active or in the convalescent stage, and probably with
a minimum of patient intermingling. Scott4 treated 50 individuals
exposed to Sonne dysentery with 1.5 gm. of sulfaguanidine per day
for about 7 days. The drug was started on the fifteenth day of the
outbreak after 20 cases had already occurred. No further cases
developed. There was no control group, and the possibility that
most of the susceptible individuals were already involved when the
drug was started makes this study difficult to evaluate.
While the evidence in the present study is not entirely satisfac-
tory, the possibility that a single dose of a rapidly absorbed sulfon-
amide drug like sulfathiazole may control the spread of dysentery
under certain conditions is suggestive. Its use for this purpose in
bacillary dysentery would appear more logical at the onset of an
explosive outbreak, such as might occur following the ingestion by
a large number of individuals of a contaminated food. While the
immediate symptoms in such an event are usually those of a severe
food poisoning, the isolation of the dysentery organism by rectal
swab or from the offending food, or the subsequent development,
within 3 to 6 days, of cases of typical acute bacillary dysentery will
indicate the true nature of the outbreak. Under other conditions,
the poorly absorbed sulfonamide drugs, like sulfaguanidine or suc-
cinyl sulfathiazole, would appear to be the drugs of choice for
prophylaxis. While the optimal dose or period of administration
for these drugs is not definitely established, it is clear that dosages
of one-quarter to one-third of those recommended for therapeutic
purposes, administered for 10 to 14 days, are effective.
Summary
An outbreak of Sonne bacillary dysentery in an institution for
mental defectives is described. An opportunity was afforded to
test the value of sulfaguanidine when employed during the early
convalescent stage to shorten the carrier state. When used iii the
manner and dosage described, no significant reduction in the period
during which the dysentery bacilli were recovered could be
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demonstrated. It is felt that the dose used, roughly one-quarter of
that recommended for therapeutic purposes, might have been
inadequate.
In 2 cottages, it was possible to carry out adequately controlled
experiments on the value of sulfaguanidine when used as a prophy-
lactic measure in preventing bacillary dysentery. In both cottage
groups successful prevention of the disease was demonstrated.
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